Edge Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
CFGS
RJA
MCM
SPIA
Edge Wealth Management's IHE Position: Q3 2020 in Review
Edge Wealth Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2020, closing a stake of 3,327 shares — an estimated $171K sold.
Edge Wealth Management first reported a position in IHE in Q2 2013 and held it in 29 quarters. The position peaked at $268K in Q2 2015. 94 funds tracked by Wall St. Rank hold IHE as of Q3 2020.
- Edge Wealth Management reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2020 after selling out during the quarter.
- Edge Wealth Management sold 3,327 iShares US Pharmaceuticals ETF shares in Q3 2020, an estimated $171K.
- Edge Wealth Management first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 29 quarters.
- Edge Wealth Management's iShares US Pharmaceuticals ETF position peaked at $268K in Q2 2015.
- 94 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2020.
Based on Edge Wealth Management's 13F filing for Q3 2020, filed 21 Oct 2020.